These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10740142)

  • 1. Endothelial cell dysfunction correlates differentially with survival in primary and secondary pulmonary hypertension.
    Lopes AA; Maeda NY; Gonçalves RC; Bydlowski SP
    Am Heart J; 2000 Apr; 139(4):618-23. PubMed ID: 10740142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating von Willebrand factor antigen as a predictor of short-term prognosis in pulmonary hypertension.
    Lopes AA; Maeda NY
    Chest; 1998 Nov; 114(5):1276-82. PubMed ID: 9824001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in circulating von Willebrand factor and survival in pulmonary hypertension.
    Lopes AA; Maeda NY; Bydlowski SP
    Am J Med; 1998 Jul; 105(1):21-6. PubMed ID: 9688017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Von Willebrand factor and pulmonary endothelial dysfunction. Prognostic implications].
    Lopes AA; Maeda NY; Bydlowski SP
    Arq Bras Cardiol; 1998 Mar; 70(3):141-5. PubMed ID: 9674173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal endothelial factor VIII associated with pulmonary hypertension and congenital heart defects.
    Rabinovitch M; Andrew M; Thom H; Trusler GA; Williams WG; Rowe RD; Olley PM
    Circulation; 1987 Nov; 76(5):1043-52. PubMed ID: 3117409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of von Willebrand factor in primary pulmonary hypertension.
    Collados MT; Sandoval J; López S; Massó FA; Páez A; Borbolla JR; Montaño LF
    Heart Vessels; 1999; 14(5):246-52. PubMed ID: 10830921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase type 5 inhibitors improve microvascular dysfunction markers in pulmonary arterial hypertension associated with congenital heart disease.
    Clavé MM; Maeda NY; Thomaz AM; Bydlowski SP; Lopes AA
    Congenit Heart Dis; 2019 Mar; 14(2):246-255. PubMed ID: 30343508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of life expectancy in patients with primary pulmonary hypertension. A retrospective nationwide survey from 1980-1990.
    Okada O; Tanabe N; Yasuda J; Yoshida Y; Katoh K; Yamamoto T; Kuriyama T
    Intern Med; 1999 Jan; 38(1):12-6. PubMed ID: 10052735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. von Willebrand factor abnormalities in primary pulmonary hypertension.
    Geggel RL; Carvalho AC; Hoyer LW; Reid LM
    Am Rev Respir Dis; 1987 Feb; 135(2):294-9. PubMed ID: 3101558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma von Willebrand factor as a predictor of survival in pulmonary arterial hypertension associated with congenital heart disease.
    Lopes AA; Barreto AC; Maeda NY; Cícero C; Soares RP; Bydlowski SP; Rich S
    Braz J Med Biol Res; 2011 Dec; 44(12):1269-75. PubMed ID: 22068906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial dysfunction associated with chronic intravascular coagulation in secondary pulmonary hypertension.
    Lopes AA; Caramurú LH; Maeda NY
    Clin Appl Thromb Hemost; 2002 Oct; 8(4):353-8. PubMed ID: 12516685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of tetramethylpyrazine on endothelin, von Willebrand factor and thromboxane A2 during cardiopulmonary bypass in patients of congenital heart disease with pulmonary hypertension].
    Huang RJ; Liao CX; Chen DZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2003 Apr; 23(4):268-71. PubMed ID: 12764908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. von Willebrand factor independently predicts long-term survival in patients with pulmonary arterial hypertension.
    Kawut SM; Horn EM; Berekashvili KK; Widlitz AC; Rosenzweig EB; Barst RJ
    Chest; 2005 Oct; 128(4):2355-62. PubMed ID: 16236894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of von Willebrand factor in adult patients with congenital heart disease.
    Ohuchi H; Hayama Y; Miike H; Suzuki D; Nakajima K; Iwasa T; Konagai N; Sakaguchi H; Miyazaki A; Shiraishi I; Kurosaki KI; Nakai M
    Heart; 2020 Jun; 106(12):910-915. PubMed ID: 32188625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent likelihood of in situ thrombosis in secondary pulmonary hypertension.
    Caramuru LH; Maeda NY; Bydlowski SP; Lopes AA
    Clin Appl Thromb Hemost; 2004 Jul; 10(3):217-23. PubMed ID: 15247978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis.
    Horvatits T; Drolz A; Roedl K; Herkner H; Ferlitsch A; Perkmann T; Müller C; Trauner M; Schenk P; Fuhrmann V
    J Hepatol; 2014 Sep; 61(3):544-9. PubMed ID: 24798623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal multimeric and oligomeric composition is associated with enhanced endothelial expression of von Willebrand factor in pulmonary hypertension.
    Lopes AA; Maeda NY; Aiello VD; Ebaid M; Bydlowski SP
    Chest; 1993 Nov; 104(5):1455-60. PubMed ID: 8222806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of plasma asymmetric dimethyl-L-arginine levels in detection of pulmonary hypertension in children with CHD.
    Farag M; El Amrousy D; El-Serogy H; Zoair A
    Cardiol Young; 2018 Sep; 28(9):1163-1168. PubMed ID: 29950194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial dysfunction marker von Willebrand factor antigen in haemodialysis patients: associations with pre-dialysis blood pressure and the acute phase response.
    Borawski J; Naumnik B; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2001 Jul; 16(7):1442-7. PubMed ID: 11427638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary arterial capacitance in children with idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with congenital heart disease: relation to pulmonary vascular resistance, exercise capacity, and survival.
    Sajan I; Manlhiot C; Reyes J; McCrindle BW; Humpl T; Friedberg MK
    Am Heart J; 2011 Sep; 162(3):562-8. PubMed ID: 21884877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.